Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Invested Capital (2016 - 2025)

Historic Invested Capital for Dare Bioscience (DARE) over the last 11 years, with Q3 2025 value amounting to $4.9 million.

  • Dare Bioscience's Invested Capital rose 42960.32% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year increase of 42960.32%. This contributed to the annual value of -$6.0 million for FY2024, which is 1902.66% down from last year.
  • Per Dare Bioscience's latest filing, its Invested Capital stood at $4.9 million for Q3 2025, which was up 42960.32% from -$10.7 million recorded in Q2 2025.
  • Dare Bioscience's Invested Capital's 5-year high stood at $38.8 million during Q4 2021, with a 5-year trough of -$11.0 million in Q1 2024.
  • Over the past 5 years, Dare Bioscience's median Invested Capital value was $4.3 million (recorded in 2021), while the average stood at $8.0 million.
  • As far as peak fluctuations go, Dare Bioscience's Invested Capital soared by 2564112.88% in 2021, and later plummeted by 50191.79% in 2025.
  • Quarter analysis of 5 years shows Dare Bioscience's Invested Capital stood at $38.8 million in 2021, then crashed by 71.33% to $11.1 million in 2022, then tumbled by 145.42% to -$5.0 million in 2023, then decreased by 19.03% to -$6.0 million in 2024, then soared by 181.44% to $4.9 million in 2025.
  • Its Invested Capital stands at $4.9 million for Q3 2025, versus -$10.7 million for Q2 2025 and -$7.2 million for Q1 2025.